Metoprolol succinate is released faster from Kapspargo Sprinkle in the presence of alcohol; may increase the risk for adverse events associated with Kapspargo Sprinkle Avoid alcohol consumption Pregnancy and Lactation There are no adequate and well-controlled studies on pregnant women Limited data on the...
Metoprolol Succinate package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.
Common Generic Name(s): metoprolol, metoprolol tartrate, metoprolol succinate Pronunciation: me-TOE-proe-lole Drug Classes: beta-1 selective beta-adrenergic blocking agent Availability: prescription only, generic available How is it used? capsule or tablet that is swallowed, liquid that is injected ...
Metoprolol succinate is a white crystalline powder with a molecular weight of 652.8. It is freely soluble in water; soluble in methanol; sparingly soluble in ethanol; slightly soluble in dichloromethane and 2-propanol; practically insoluble in ethyl-acetate, acetone, diethylether and heptane. Inactive...
Metoprolol Succinate Extended Release Tablets: 25 mg orally once a day (12.5 mg orally once a day in patients with more severe heart failure); double dose every 2 weeks to highest tolerated dose or up to 200 mg orally once a day.
capsule, extended-release (Kapspargo Sprinkle [as succinate]) 25mg 50mg 100mg 200mg Hypertension Lopressor 100 mg/day PO initially in single dose or divided q12hr; may be increased at intervals of 1 week or longer; not to exceed 450 mg/day Toprol XL 25-100 mg PO qDay initially; may ...
Mylan Institutional Inc.: Metoprolol succinate extended-release tablets are a beta-adrenergic blocker indicated for the treatment of: Hypertension, to lower...
metoprolol succinatearterial hypertensionantihypertensive therapyAim. To study efficiency and safety of new drug of long acting metoprolol tartrate, "Egilok retard" (ER) in patients with mild to moderate arterial hypertension (AH) in comparison with the original drug of metoprolol succinat, "Betaloc ...
Aim. To compare two initial doses (50 or 100mg/day) ofmetoprolol succinate in control released presentation (Betaloc ZOK, AstraZeneca) for achievement of target level of heart rate (HR) in patients with stable course of ischemic heart disease (IHD).Material and methods. 50 patients (34 men...
Extended-release capsules (succinate; Kapspargo Sprinkle):25 mg, 50 mg, 100 mg, 200 mg Extended-release tablets (succinate; Toprol XL):25 mg, 50 mg, 100 mg, 200 mg Solution for injection:1 mg/mL In Combination with:hydrochlorothiazide (Lopressor HCT). Seecombination drugs. ...